GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Hold MDT
up 12.56 %

Medtronic, Inc. (MDT) downgraded to Hold by Standpoint Research

Posted on: Monday,  Dec 5, 2011  11:25 AM ET by Standpoint Research

Standpoint Research rated Hold Medtronic, Inc. (NYSE: MDT) on 12/05/2011. Previously Standpoint Research rated Accumulate Medtronic, Inc. (NYSE: MDT) on 08/15/2011.,
when the stock price was $31.99. Since then, Medtronic, Inc. has gained 12.57% as of 12/05/2011's recent price of $36.01.
If you would have followed the previous Standpoint Research's recommendation on MDT, you would have gained 12.56% of your investment in 112 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2011 11:25 AM Hold
None
36.01
as of 12/30/2011
1 Week   
1 Month down  -1.15 %
3 Months up  8.33 %
1 YTD up  12.56 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/15/2011 10:25 AM Buy
None
31.99 38.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy